Teijin : Japan Tissue Engineering Wins Approval for Insurance Coverage of JACC,Its First-in-Japan Therapy for Autologous Cartilage Repair in Knee Osteoarthritis

Jan. 22, 2026 News Release

Japan Tissue Engineering Co., Ltd. (Headquarters: Gamagori, Aichi Prefecture; President: Kazuto Yamada) announces that it held a media briefing regarding autologous cultured cartilage, which became eligible for insurance coverage for knee osteoarthritis as of January 1, 2026.This briefing is based on previously disclosed information-namely, the approval of the indication expansion on May 13, 2025, and the subsequent insurance listing on January 1, 2026-and does not contain any discrepancies from the timely disclosure published on December 29, 2025 (nor does it constitute the disclosure of any new material facts).

News Release on autologous cultured cartilage (PDF)

Regenerative medicine for knee cartilage